Sydney Lupkin

5 things we found in the FDA’s hidden device database Sydney Lupkin
Consumers rejected drug plan that mirrors Trump administration proposal Sydney Lupkin
Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale Sydney Lupkin
Pfizer settles kickback case related to copay assistance for $24M Sydney Lupkin
Drugmakers blamed for blocking generics have jacked up prices Sydney Lupkin
Patients overpay for prescriptions 23% of the time, analysis shows Sydney Lupkin
Drugmakers dramatically boosted lobbying spending in Trump’s first quarter Sydney Lupkin
Page: 1